Neurogene Announces Successful Completion of Dosing in Embolden(TM) Registrational Trial of NGN-401 for Rett Syndrome
June 8, 2026
Health
-
-
Standard BioTools and Treeline Biosciences Announce Merger Agreement
June 8, 2026
-
Nuwellis Announces Pricing of $6 Million Public Offering
June 5, 2026
-
Trulieve Announces Uplist to NYSE
June 5, 2026
-
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer
June 2, 2026
-
HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home
June 2, 2026
-
Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus
June 1, 2026
-
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory
June 1, 2026
-
Glass House Brands Completes Previously Announced Warrant Redemption
May 29, 2026
-
EDAP Announces Corporate Name Change to FocalTherics(TM) to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
May 29, 2026
-
BioNexus Gene Lab Corp. Calls for Malaysia-China Biotechnology Cooperation to Move Beyond Trade into Co-Development
May 29, 2026
-
Sharps Technology Becomes SkyAI, Inc. with New Ticker Symbol “SKYA”; Establishing Category-defining Agentic Finance Platform Serving Global South
May 27, 2026
-
CareCloud Acquires Empower Healthcare & Compliance Partners, adding a High-Growth Compliance Business to its AI-powered Platform
May 26, 2026
-
Management and Customers Detail Four Strategic Themes, an AI-First Operating Model, a Clean Common-Stock Story, Compounding Free Cash Flow and a Proven Acquisition Engine
May 21, 2026
-
Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts
May 19, 2026
-
CATHETER PRECISION REPORTS 200% REVENUE GROWTH AND COMPLETES TRANSFORMATIVE FLYTE ACQUISITION
May 18, 2026